Isabella Ciccone, Associate Editor, NeurologyLive®, has been with the team since September 2022. Follow her on Twitter @iciccone7 or email her at iciccone@mjhlifesciences.com
Clinical Perspective on Newly Approved Combination Therapy for Migraine: Richard B. Lipton, MD
February 4th 2025The director of the Montefiore Headache Center at Albert Einstein College of Medicine discussed the recent FDA approval of a new migraine treatment that combines rizatriptan and meloxicam. [WATCH TIME: 5 minutes]
FDA Approves Vertex Pharmaceuticals' Suzetrigine for Acute Pain Management
Published: January 30th 2025 | Updated: February 21st 2025Suzetrigine, a selective inhibitor of the NaV1.8 sodium channel, offers an alternative opioid treatment option for patients to treat moderate to severe pain without risk of addiction.
Multiple System Atrophy Agent ATH434 Shows Promising Topline Efficacy in Phase 2 Trial
Published: January 30th 2025 | Updated: February 3rd 2025Recent results from a phase 2 trial of ATH434 revealed its potential in reducing brain iron accumulation and preserving motor function in early-stage multiple system atrophy.
Updates in Therapeutic Development: Clinical Trial Readouts to Watch in the First Half of 2025
January 29th 2025Explore some of the most highly anticipated clinical trials with data readouts expected in the second half of 2025—key updates that researchers and clinicians in neurology won’t want to miss.
Insights From the Pediatric Epilepsy Research Consortium on Advancing Genetic Testing
January 29th 2025A duo of experts discussed the importance of addressing barriers such as provider comfort, access to genetic counselors, and insurance coverage to reduce diagnostic latency and standardize genetic testing for epilepsy. [WATCH TIME: 5 minutes]
Enhancing Multiple Sclerosis Diagnosis and Early Treatment Strategies: David A. Hafler, MD, FANA
January 29th 2025The William S. and Lois Stiles Edgerly Professor of Neurology at Yale School of Medicine talked about refining multiple sclerosis in line with the updated diagnostic criteria. [WATCH TIME: 5 minutes]
Pediatric AES Insights: Addressing Health Disparities and Advancing Neonatal Epilepsy Care
January 26th 2025Pediatric epilepsy specialists Adam Numis, MD, and Laura Kirkpatrick, MD, highlighted efforts to standardize data collection for pediatric epilepsy health equity and improve neonatal epilepsy outcomes.
Improving MS Management Through Early Intervention and Precision Medicine: Emilio Portaccio, MD
January 22nd 2025The professor of neurology at University of Florence talked about how early intervention, broader assessment tools, and personalized approaches are essential for effectively managing multiple sclerosis. [WATCH TIME: 4 minutes]
Exploring the Role of Viruses and Immune Responses in Alzheimer Disease: Or Shemesh, PhD
January 21st 2025The assistant professor at The Hebrew University of Jerusalem School of Pharmacy discussed how the brain microbiome may contribute to Alzheimer through interactions with immune responses and proteins. [WATCH TIME: 5 minutes]
Bridging Clinical Signs and Biological Evidence to Transform MS Diagnosis: Marcello Moccia, MD, PhD
January 20th 2025At ECTRIMS 2024, the assistant professor at the University of Naples the latest multiple sclerosis diagnostic criteria, which emphasized a shift toward biologically based diagnoses. [WATCH TIME: 4 minutes]
Early Immunotherapy May Be Crucial to Prevent Axonal Damage in CIDP, Study Suggests
Published: January 20th 2025 | Updated: February 3rd 2025A new study highlighted the importance of initiating immunotherapy promptly in chronic inflammatory demyelinating polyneuropathy to prevent axonal damage and disability progression.
Navigating the Decision to Treat Multiple Sclerosis Early Versus Later: Mikael Cohen, MD
January 20th 2025At the 2024 ECTRIMS Congress, the neurologist at the University Hospital Center of Nice talked about how the decision to treat patients at risk of MS is highly individualized. [WATCH TIME: 3 minutes]
Improving MS Diagnosis Through Biology and Early Detection: Wallace Brownlee, MBChB, PhD, FRACP
January 19th 2025At ECTRIMS 2024, the consultant neurologist at Queen's Square MS Center in London talked about the evolving McDonald criteria to define multiple sclerosis biologically. [WATCH TIME: 5 minutes]